Skip to content
IP + Technology Law
Home  »  News & Insights  »  News

Partner Joseph Mallon, Ph.D. quoted in, “Big Pharma Creating Startup Firms to Do Drug Research.”

October 11, 2017  | Joseph Mallon, Ph.D.

Partner Joseph Mallon, Ph.D. quoted in, “Big Pharma Creating Startup Firms to Do Drug Research,” an article published in Healthline.

Excerpt: Pfizer and several other firms have invested in a small spinoff company that will develop drug therapies for underserved patients.

Read Full Article Here >>

 

Partner Joseph Mallon, Ph.D. quoted in, “Big Pharma Creating Startup Firms to Do Drug Research.” Headshot

Joseph Mallon, Ph.D.

Joe’s practice includes intellectual property due diligence, Patent Office appeals, preparation and prosecution of patent applications, and counseling on patent strategy, patent infringement and licensing issues. He represents clients in...

Related Links

Practice Areas

Industries

News & Insights

Blog - Biotechnology
Nov 2024
FDA Provides Perspective on Goals and Challenges for Regulation of Artificial Intelligence in Medical Devices, Drug Design, and Clinical Research
A recent article[1] authored by Haider J. Warraich, MD[2]; Troy Tazbaz[3]; and Robert M. Califf[4], MD in the Journal of the American Medical Association, reviews the history of artificial intelligence...
News
Nov 2024
Steve Jensen and Joseph Re Featured in OC500 List by Orange County Business Journal
IRVINE, Calif., November 22, 2024 – Knobbe Martens is pleased to share that partners Steve Jensen and Joseph Re have been named to the OC500, Orange County Business Journal’s annual...
Blog - Medical Devices & Procedures
Nov 2024
Teva v. Amneal Oral Arguments and Claim Construction Order: Recent Developments in the Ongoing Debate Over the Orange Book Listing of Device Patents
As the FTC continues to crack down on pharmaceutical manufacturers’ allegedly improper listing of patents in the FDA Orange Book, counsel for Teva and Amneal presented oral arguments in the Court of Appeals for the Federal Circuit on November 8,...